Investment Q&A

• Fulgent Genetics Inc. (FLGT $27.85)
  • $27.85 Cap: $860M
  • View FLGT Profile
  • View Questions on FLGT

Q: comments on their quarter? Are you guys becoming more interested in this name given it's performance recently?

Upvote 0

Read Answer Asked by Daniel on November 10, 2020

• Biogen Inc. (BIIB $187.62)
  • $187.62 P/E (TTM): 16.97X Cap: $27.52B
  • View BIIB Profile
  • View Questions on BIIB

Q: Is BIIB a buy with its large fall? or is it watch-and-see?
What are your thoughts?
Thanks so much!
PS It's good to have a friend we can turn to.

Upvote 0

Read Answer Asked by Sam on November 09, 2020

• BioVaxys Technology Corp. (BIOV $0.25)
  • $0.25 Cap: $6M
  • View BIOV Profile
  • View Questions on BIOV

Q: Thoughts on this company?

Upvote 0

Read Answer Asked by Dustin on November 09, 2020

• WELL Health Technologies Corp. (WELL $4.23)
  • $4.23 Cap: $1.07B
  • View WELL Profile
  • View Questions on WELL
  • View Reports on WELL

Q: Hi Team,

What do you think of the purchase by WELL this morning? Are they issuing shares to pay for the transaction?

Thanks!

Upvote 0

Read Answer Asked by David on November 09, 2020

• Mirati Therapeutics Inc. (MRTX)
  • Cap: $4.11B
  • View MRTX Profile
  • View Questions on MRTX

Q: Good day team,
Can you please tell me what you think about this company? They recently announced a public offering of four million new shares and despite the greater number of shares the stock price didn’t drop.

Upvote 0

Read Answer Asked by Marco on November 09, 2020

• WELL Health Technologies Corp. (WELL $4.23)
  • $4.23 Cap: $1.07B
  • View WELL Profile
  • View Questions on WELL
  • View Reports on WELL

Q: Well has now announced another acquisition. INSIG Corporation, following 51% ownership position in Integrated Allied Health Services earlier this month. Do you feel that a stock offering will be required to support these moves?

Upvote 0

Read Answer Asked by Dave on November 09, 2020

• BioNTech SE (BNTX $99.85)
  • $99.85 Cap: $23.96B
  • View BNTX Profile
  • View Questions on BNTX

Q: Does today's price have a baked in value of the vaccine passing the fda approval or can we expect it to double or triple after approval.

Upvote 0

Read Answer Asked by Steve on November 09, 2020

• Bristol-Myers Squibb Company Celegne Contingent Value Rights (CELG.R $0.15)
  • $0.15 P/E (TTM): 18.82X Cap: $115.46B
  • View CELG.R Profile
  • View Questions on CELG.R

Q: Is there going to be value left in these rights? A very tiny fraction of portfolio left over from BMY buying Celgene. What are my options here and what are your thoughts/suggestions. I thank you in advance.

Upvote 0

Read Answer Asked by Tulio on November 09, 2020

• Knight Therapeutics Inc. (GUD $5.98)
  • $5.98 Cap: $596M
  • View GUD Profile
  • View Questions on GUD
  • View Reports on GUD

Q: Knight releases Q3 earnings this Friday 13 Nov. Whats the expectations ? Any feelings wrt increasing exposure before Friday ? Thank you.

Upvote 0

Read Answer Asked by Paul on November 09, 2020

• Viemed Healthcare Inc. (VMD $7.24)
  • $7.24 P/E (TTM): 21.91X Cap: $275M
  • View VMD Profile
  • View Questions on VMD
• WELL Health Technologies Corp. (WELL $4.23)
  • $4.23 Cap: $1.07B
  • View WELL Profile
  • View Questions on WELL
  • View Reports on WELL

Q: Please comment on earnings. Stock seems to have lost some pizzazz. Is it time to take the money and run?

I would like to see a weekly earnings calendar. The TMX site used to provide this service but no longer does. I would at least like to see projected reporting dates in company profiles.

Thanks for your consideration.

Upvote 0

Read Answer Asked by Doug on November 06, 2020

• Protech Home Medical Corp. (PTQ)
  • P/E (TTM): -32.3X Cap: $232M
  • View PTQ Profile
  • View Questions on PTQ

Q: Long-time PTQ (old PHM) holder. PTQ has been on quite a run recently, could you provide some insight in to what is behind the rise in share price and your thoughts on the company in general? Thanks!

Upvote 0

Read Answer Asked by Jeff on November 06, 2020

• AbbVie Inc. (ABBV $220.08)
  • $220.08 P/E (TTM): 171.09X Cap: $388.96B
  • View ABBV Profile
  • View Questions on ABBV
• Medtronic plc. (MDT $97.53)
  • $97.53 P/E (TTM): 26.67X Cap: $125.03B
  • View MDT Profile
  • View Questions on MDT
• Bausch Health Companies Inc. (BHC $10.33)
  • $10.33 P/E (TTM): 8.09X Cap: $3.80B
  • View BHC Profile
  • View Questions on BHC

Q: BHC has dropped after earnings. Pls comment the earning. How does the future look for this company? I have 1% in my portfolio, would you suggest to hold or sell the stock now?

Upvote 0

Read Answer Asked by David on November 06, 2020

• Global Blood Therapeutics Inc. (GBT)
  • View GBT Profile
  • View Questions on GBT

Q: Opinion on GBT latest results and investment moving forward.

thanks Dave

Upvote 0

Read Answer Asked by Dave on November 06, 2020

• Invitae Corporation (NVTA)
  • Cap: $5M
  • View NVTA Profile
  • View Questions on NVTA

Q: Good Morning... your thoughts on NVTA's earnings please, and the company's progress in general.

thanks, Mark

Upvote 0

Read Answer Asked by Mark on November 06, 2020

• Carebook Technologies Inc. (CRBK $0.10)
  • View CRBK Profile
  • View Questions on CRBK

Q: Your thoughts on Carebook Technologies please.Thanks.

Upvote 0

Read Answer Asked by maurice on November 05, 2020

• Harvest Healthcare Leaders Income ETF (HHL $7.89)
  • $7.89 P/E (TTM): 23.05X Cap: $1.63B
  • View HHL Profile
  • View Questions on HHL

Q: Can you please comment on HHL. This ETF pays a dividend of about 9% and seems to be very stable. My only other healthcare holding is a small position in WELL. Should HHL be held in my RSP, TFSA or CASH account.
Thanks!

Upvote 0

Read Answer Asked by Grant on November 05, 2020

• Teladoc Health Inc. (TDOC $7.46)
  • $7.46 Cap: $1.32B
  • View TDOC Profile
  • View Questions on TDOC
• WELL Health Technologies Corp. (WELL $4.23)
  • $4.23 Cap: $1.07B
  • View WELL Profile
  • View Questions on WELL
  • View Reports on WELL

Q: What is your opinion on Teladoc in the healthcare space?

Upvote 0

Read Answer Asked by Shawn on November 04, 2020

• AbbVie Inc. (ABBV $220.08)
  • $220.08 P/E (TTM): 171.09X Cap: $388.96B
  • View ABBV Profile
  • View Questions on ABBV

Q: Good morning

What is up with Abbvie today? Its up over $7.00

What am I missing?

Thanks

Upvote 0

Read Answer Asked by Jimmy on November 04, 2020

• Knight Therapeutics Inc. (GUD $5.98)
  • $5.98 Cap: $596M
  • View GUD Profile
  • View Questions on GUD
  • View Reports on GUD

Q: Why do you think the markets have been negative on GUD lately? Their last few quarters have shown significant growth in income. I show GUD down about 28% on the year. Thanks.

Upvote 0

Read Answer Asked by Robert on November 04, 2020

• Fusion Pharmaceuticals Inc. (FUSN)
  • View FUSN Profile
  • View Questions on FUSN

Q: Do you consider that today's news of a joint agreement with Astra Seneca is significant enough to open a full position in Fusion? My read is that the agreement confirms that AZ believes FUSION has the goods so to speak, and is relieving them of a huge part of the costs of development in exchange for a piece of the action. I like the deal but would like your opinion before I jump.
John

Upvote 0

Read Answer Asked by JOHN on November 03, 2020